Adjuvant Therapy
Adjuvant therapy is a treatment done after the primary treatment, e.g. surgery, to decrease the chance of the ocular melanoma returning or spreading. It can also refer to any treatment used in addition to the primary form of treatment.
Currently, in ocular melanoma, all adjuvant treatments are in the clinical trial stage and nothing yet has been proven to show beneficial results.
The Cleveland Clinic's Arun Singh has an interesting paper from 2014 on the topic here.
And a more recent paper looks at the Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. Unfortunately, there was no increase in survival rate for the treated patients.
Currently, in ocular melanoma, all adjuvant treatments are in the clinical trial stage and nothing yet has been proven to show beneficial results.
The Cleveland Clinic's Arun Singh has an interesting paper from 2014 on the topic here.
And a more recent paper looks at the Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. Unfortunately, there was no increase in survival rate for the treated patients.
Introduction
Primary Tumor Treatments
Radiation Treatments
Enucleation / Resection
> Adjuvant Therapy
Metastatic Disease Treatments
Targeted Radiation
Transarterial Chemotherapy
Other Liver Treatments
Systemic Treatments
Clinical Trials
Frontier Treatments
Diet & Lifestyle
Living with OM
Primary Tumor Treatments
Radiation Treatments
Enucleation / Resection
> Adjuvant Therapy
Metastatic Disease Treatments
Targeted Radiation
Transarterial Chemotherapy
Other Liver Treatments
Systemic Treatments
Clinical Trials
Frontier Treatments
Diet & Lifestyle
Living with OM